Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at docetaxel and rhenium 186 for people with prostate cancer that had spread to the bones

Overview

Cancer types:

Prostate cancer

Status:

Results

Phase:

Phase 1

Details

This trial looked at combining docetaxel and rhenium 186 for prostate cancer that had spread to the bones. It recruited men whose cancer was no longer responding to hormone therapy.

Recruitment start: 10 September 2007

Recruitment end: 16 November 2009

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Prof J. O’Sullivan

Supported by

Belfast City Hospital HPSS Trust

Covidien Mallinckrodt

Experimental Cancer Medicine Centre (ECMC)

National Institute for Health Research Cancer Research Network (NCRN)

Sanofi

Last reviewed: 24 May 2012

CRUK internal database number: 997

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.